Most Effective Contribution to Clinical Redesign

Most Effective Contribution to Clinical Redesign
Most Effective Contribution to Clinical Redesign
Read more

How to apply

Entries are now closed

Treatment pathways are crucial for the management of patient care and should be evidence based, appropriate and relevant to the individual. More than just a protocol they should be a linked series of practices which serve the specific diagnosis. With high demand for integrated pathways between services, institutions and providers there is more emphasis on changing or updating the structures and management for the benefit of patients. 

Winners of this award will be a business which has been working in partnership with an NHS organisation to substantially improve the service and redesign treatments, departments or service connections in a specific area. Judges will be looking for tangible transformation in the approach to treatment with new systems and processes, recording techniques, technology and training. Evidence will be represented by improved efficiency, capacity and patient outcomes. 

Eligibility

  • Entrants will be a pharmaceutical, consultant, private healthcare provider or other entity outside the NHS which has made substantial changes to the treatment pathways for patients in a specific treatment area 
  • Judges are looking for evidence on projects ongoing or completed in the past 2 years up until the awards entry deadline 
  • Evidence will be based on a single project for an NHS organisation

Ambition

  • Describe the context within which a transformation or redesign was necessary.  
  • What were the goals and what tools were employed to effect change?  
  • Share how the project or programme was designed to ensure long-term sustainable change  

Outcome

  • What were the measures of success and how were the achieved against the goals laid out at the commencement of the project?  
  • How did the scope of work or goals change throughout the project, and what checks were put in place to ensure these delivered value for money?  
  • Describe key financial outcome metrics as well as clearly demonstrated improvements in patient outcomes, treatment pathways and experiences as a direct result of the transformation  

Spread

  • If successful has the transformation project been replicated elsewhere?  
  • Describe with evidence how spreading best practice has been considered in the design of the project. Have the stakeholders used the learnings in other pathways within or outside the NHS body?

Involvement 

  • When designing a pathway transformation what consideration has been given to end-users including staff and patients?  
  • How has the project involved these groups to ensure the goals consider the people as well as the organisation?  
  • Judges are looking for evidence of involvement including testimonials and stakeholder buy-in. 

Value

  • Describe the return on investment of time and money by all partners in this project 
  • To what extent has the partnership led to material and measurable improvements in both financial and non-monetary value?  
  • Demonstrate with evidence any additional value creation for patients and staff  

To find out more

For entry enquiries, contact James Elliot on james.elliott@wilmingtonplc.com